Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck
Samantha Tam, Christopher M. K. L. Yao, Moran Amit, et al.
JAMA Otolaryngology–Head & Neck Surgery (2019) Vol. 146, Iss. 2, pp. 128-128
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 16, pp. 4557-4565
Open Access | Times Cited: 101
Paraneoplastic neurological syndromes: clinical presentations and management
Michelle F. Devine, Naga Pradyumna Kothapalli, Mahmoud Elkhooly, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 60
Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
Nicole Chizara Oparaugo, Kelsey Ouyang, Nam Phuong N. Nguyen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1527-1527
Open Access | Times Cited: 28
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma
George A. Zakhem, Akshay Pulavarty, John A. Carucci, et al.
JAMA Dermatology (2022) Vol. 159, Iss. 2, pp. 160-160
Open Access | Times Cited: 25
Gene expression landscape of cutaneous squamous cell carcinoma progression
Tomas Bencomo, Carolyn Lee
British Journal of Dermatology (2024)
Open Access | Times Cited: 5
Epidemiology of advanced cutaneous squamous cell carcinoma
Clio Dessinioti, Matthaios Pitoulias, Alexander J. Stratigos
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. 1, pp. 39-50
Closed Access | Times Cited: 32
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts
Ignazio Stanganelli, Francesco Spagnolo, Giuseppe Argenziano, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 377-377
Open Access | Times Cited: 22
Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field
Senait Ashenafi, Susanna Brighenti
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death
Teo Soleymani, David G. Brodland, Julia Arzeno, et al.
Journal of the American Academy of Dermatology (2022) Vol. 88, Iss. 1, pp. 109-117
Open Access | Times Cited: 19
Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma
Kevin L. Li, Cecelia E. Schmalbach
Otolaryngology (2025)
Closed Access
Effectiveness and Toxicity of Cemiplimab Therapy for Advanced Cutaneous Squamous Cell Skin Cancer in a Community Oncology Practice
Tina Fung, Wolfram E. Samlowski, Raul T. Meoz
Cancers (2025) Vol. 17, Iss. 5, pp. 823-823
Open Access
Electrochemotherapy for Multiple Nonmelanoma Skin Tumors in Immunosuppressed Patients: A Prospective Cohort Analysis
Petra Rózsa, Benjamin Tamás Papp, Edit Szederkényi, et al.
Dermatologic Therapy (2025) Vol. 2025, Iss. 1
Open Access
Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma
Clio Dessinioti, Alexander J. Stratigos
Cancers (2022) Vol. 14, Iss. 14, pp. 3556-3556
Open Access | Times Cited: 18
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma
Alesha A. Thai, Richard J. Young, Mathias Bressel, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 588-602
Closed Access | Times Cited: 8
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre
Erica C. Koch Hein, Maysa Vilbert, Ian Hirsch, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4312-4312
Open Access | Times Cited: 8
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib
Alexandros Rampotas, Luke Carter‐Brzezinski, Tim C. P. Somervaille, et al.
Blood (2023) Vol. 143, Iss. 2, pp. 178-182
Closed Access | Times Cited: 8
Review of recent advances in managing periocular skin malignancies
Daniel C. Trotier, Leslie Huang, Suzanne W. van Landingham, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease
Daniel O’Connor, Fadi Murad, Melissa Danesh, et al.
Journal of the American Academy of Dermatology (2022) Vol. 87, Iss. 6, pp. 1295-1302
Closed Access | Times Cited: 11
Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer
Connor H. O’Meara, Zuhayr Jafri, Levon M. Khachigian
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11695-11695
Open Access | Times Cited: 6
The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
Chia Yuen Chong, Michelle Goh, Sandro Porceddu, et al.
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 25-40
Closed Access | Times Cited: 10
Hemidesmosomal Reactivity and Treatment Recommendations in Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid—A Retrospective, Monocentric Study
Franziska Schauer, David Rafei‐Shamsabadi, Shoko Mai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
Kathryn Chen, Joel Yong, Roland Zauner, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5564-5564
Open Access | Times Cited: 8
High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review
Flora Yan, Brittny Tillman, Rajiv I. Nijhawan, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 13, pp. 9009-9030
Closed Access | Times Cited: 11
Recommendations for risk stratification of periocular squamous cell carcinoma
Jessica Y. Tong, Shyamala C. Huilgol, Craig James, et al.
Survey of Ophthalmology (2023) Vol. 68, Iss. 5, pp. 964-976
Closed Access | Times Cited: 4
Sentinel lymph node biopsy versus observation in high‐risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study
A. Tejera‐Vaquerizo, Álvaro Gómez‐Tomás, Ane Jaka, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 8, pp. 1588-1598
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top